Cleared Traditional

K192665 - Accelerate Pheno System, Accelerate PhenoTest BC Kit (FDA 510(k) Clearance)

Sep 2020
Decision
356d
Days
Class 2
Risk

K192665 is an FDA 510(k) clearance for the Accelerate Pheno System, Accelerate PhenoTest BC Kit. This device is classified as a Positive Blood Culture Identification And Ast Kit (Class II - Special Controls, product code PRH).

Submitted by Accelerate Diagnostics, Inc. (Tucson, US). The FDA issued a Cleared decision on September 15, 2020, 356 days after receiving the submission on September 25, 2019.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.1650. Fluorescence In Situ Hybridization (fish) Identification And Quantitative, Antimicrobial Susceptibility Testing (ast) Kit Intended For Simultaneous Detection And Identification Of Multiple Microbial Targets..

Submission Details

510(k) Number K192665 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 25, 2019
Decision Date September 15, 2020
Days to Decision 356 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code PRH - Positive Blood Culture Identification And Ast Kit
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.1650
Definition Fluorescence In Situ Hybridization (fish) Identification And Quantitative, Antimicrobial Susceptibility Testing (ast) Kit Intended For Simultaneous Detection And Identification Of Multiple Microbial Targets.